Monarch Casino & Resort (MCRI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
13 Apr, 2026Executive summary
The annual meeting is scheduled for May 27, 2026, at the Atlantis Casino Resort Spa in Reno, Nevada, with voting eligibility for shareholders of record as of March 30, 2026.
Shareholders will vote on the election of four directors and an advisory vote on executive compensation, with the Board recommending approval of all proposals.
Proxy materials are distributed electronically to reduce costs and environmental impact, with paper copies available upon request.
Voting matters and shareholder proposals
Proposals include electing John Farahi, Craig F. Sullivan, and Paul Andrews as directors until 2028, and Hope S. Taitz until 2027.
Advisory vote on executive compensation is non-binding but will be considered in future decisions.
No statutory right of dissent applies to any proposal under Nevada law.
Shareholders may submit proposals for the 2027 meeting by December 16, 2026, and director nominations between February 24 and March 11, 2027.
Board of directors and corporate governance
The Board consists of five directors, divided into two classes with staggered two-year terms.
Three directors (Andrews, Sullivan, Taitz) are independent per Nasdaq rules.
The Board has Audit, Compensation, and Marketing Committees; the Audit and Compensation Committees are composed entirely of independent directors.
The Board reviews risk oversight, including capital structure, liquidity, and cybersecurity.
Director diversity and professional qualifications are emphasized in the nomination process.
Latest events from Monarch Casino & Resort
- Annual meeting to vote on director elections and executive compensation, board recommends approval.MCRI
Proxy filing13 Apr 2026 - Record 2025 results with strong growth, high margins, and robust capital returns.MCRI
Q4 20254 Feb 2026 - Director elections, executive pay, and governance practices are the focus of the 2025 meeting.MCRI
Proxy Filing2 Dec 2025 - Vote on director elections and executive compensation at the June 2025 annual meeting.MCRI
Proxy Filing2 Dec 2025 - Record Q3 net income, revenue, and capital returns amid ongoing litigation risks.MCRI
Q3 202528 Oct 2025 - Q2 2025 saw net income up 19.1%, a major litigation charge, and robust share repurchases.MCRI
Q2 202529 Jul 2025 - Q3 net income up 14.2% to $27.6M, with record revenue and strong shareholder returns.MCRI
Q3 202413 Jun 2025 - Q2 net income up 1.2% to $22.7M; record revenue, EBITDA, and $30.5M in buybacks.MCRI
Q2 202413 Jun 2025 - Net income up 8.7% to $19.9M, record EBITDA, but $74.6M litigation risk remains.MCRI
Q1 20256 Jun 2025